BioSight vs Curesponse

BioSight vs Curesponse, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioSight is on 37/100 and Curesponse on 55/100.

BioSight logo
BioSightClinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.
Try BioSight
Curesponse logo
CuresponsePersonalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.
Try Curesponse

Where each one leads

BioSight

Leads on none of the measures we hold for both companies.

Curesponse

  • our overall score: 55/100 against 37/100
  • domain rating: 17/100 against 12/100
  • headcount: 14 against 3
  • headcount growth: -4.3% against -30.1%
  • funding raised: $28.0M against $1.5M
  • LinkedIn following: 2,570 against 681

At a glance

MeasureBioSightCuresponse
What it isClinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.
CategoryLife Sciences, Biotech, MedTech, HealthTechLife Sciences, Cancer, Genomics, Genome Sequencing
Sells toBusiness modelB2BB2B
OfferingServicesPlatform
Founded19992017
HeadquartersTel Aviv, IsraelTel Aviv, Israel
StatusActiveInactive

Size, funding and growth

MeasureBioSightCuresponse
Employees314
Headcount growthLast 12 months-30.1%-4.3%
Total funding$1.5M$28.0M
Latest roundNot publishedSeries B
LinkedIn followers6812,570

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureBioSightCuresponse
StartupHub scoreOur 0-100 rating37/10055/100
Traction37/10049/100
TeamNot published70/100
Search visibility32/10025/100
Quality45/10058/100
Agent readinessHow well an AI agent can read and act on the siteD (46/100)D (50/100)
Domain ratingLink authority, 0-10012/10017/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureBioSightCuresponse
HostingNot detectedGoogle Cloud
CMSWixNot detected

BioSight vs Curesponse: common questions

Which is better, BioSight or Curesponse?

On our 0-100 score Curesponse rates higher (55/100 against 37/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.

How do BioSight and Curesponse compare on the numbers?

Curesponse leads on our overall score (55/100 against 37/100), domain rating (17/100 against 12/100), headcount (14 against 3), headcount growth (-4.3% against -30.1%), funding raised ($28.0M against $1.5M), LinkedIn following (2,570 against 681).

Read the full BioSight review and pricing or the Curesponse review and pricing. You can also browse other BioSight alternatives we track.